The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-(2-morpholinoethoxy)benzylidene)-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-one ID: ALA5284615
Max Phase: Preclinical
Molecular Formula: C23H23NO5
Molecular Weight: 393.44
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2ccc(OCCN3CCOCC3)cc2)Cc2cc3c(cc21)OCO3
Standard InChI: InChI=1S/C23H23NO5/c25-23-18(12-17-13-21-22(14-20(17)23)29-15-28-21)11-16-1-3-19(4-2-16)27-10-7-24-5-8-26-9-6-24/h1-4,11,13-14H,5-10,12,15H2/b18-11+
Standard InChI Key: VWIPVRYNEVNROZ-WOJGMQOQSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-3.8041 1.1085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0895 1.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3776 1.1089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3776 0.2837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0877 -0.1280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8041 0.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5929 0.0287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5928 1.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1079 0.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5920 1.3645 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.5920 0.0240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.0789 0.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3793 2.1609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2826 0.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1298 -0.0184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9551 -0.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3657 -0.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9530 -1.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1319 -1.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2844 -0.7360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3657 -2.1609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1908 -2.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6034 -1.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4286 -1.4463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8412 -0.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6664 -0.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0789 -1.4463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6664 -2.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8412 -2.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 1 0
9 7 1 0
1 10 1 0
6 11 1 0
11 12 1 0
12 10 1 0
8 13 2 0
9 14 2 0
14 15 1 0
16 15 2 0
17 16 1 0
18 17 2 0
19 18 1 0
20 19 2 0
15 20 1 0
18 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
25 24 1 0
26 25 1 0
27 26 1 0
28 27 1 0
29 28 1 0
24 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.44Molecular Weight (Monoisotopic): 393.1576AlogP: 2.95#Rotatable Bonds: 5Polar Surface Area: 57.23Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.65CX LogP: 3.16CX LogD: 3.09Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -0.56
References 1. Altıntop MD, Özdemir A, Temel HE, Demir Cevizlidere B, Sever B, Kaplancıklı ZA, Akalın Çiftçi G.. (2022) Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer., 244 [PMID:36270087 ] [10.1016/j.ejmech.2022.114851 ]